Product Information
NATESTO NASAL 5.5 MG/0.122 GM is a brand product labeled by Acerus Pharmaceuticals Corporation, priced at $41.2770 per GM under NDC 42667551101. Its NADAC has been published 186 times since May 18, 2022.
FDA first approved this application on May 28, 2014.
The High Outlier badge above means this manufacturer's average price in the testosterone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5.5 mg/.122g
Manufacturer
Acerus Pharmaceuticals CorporationNDC
42667551101
Classification
Brand
Dosage Form
GEL, METERED
Route
NASAL
Effective Date
7/22/2026
Active Ingredients
TESTOSTERONEApproval Type
New Drug (NDA)
FDA Application
NDA205488FDA Approved
5/28/2014
On Market Since
5/8/2020
Pharmacological Classes
Price Statistics
The NADAC for NATESTO NASAL 5.5 MG/0.122 GM has been published 186 times since May 18, 2022, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $41.2770 per GM |
|---|---|
| All-time high | $41.4098 (May 14, 2025) |
| All-time low | $37.6344 (May 18, 2022) |
| 52-week high | $41.3569 |
| 52-week low | $41.2770 |
| Median price | $41.2247 |
| Average price | $40.7200 |
| Largest weekly change | +5.0% (Jun 1, 2022) |
| Weeks tracked | 186 |
| Tracking since | May 18, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the testosterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acerus Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NATESTO NASAL 5.5 MG/0.122 GM?
The current National Average Drug Acquisition Cost (NADAC) for NATESTO NASAL 5.5 MG/0.122 GM, manufactured by Acerus Pharmaceuticals Corporation, is $41.2770 per GM (NDC 42667551101), effective Sep 30, 2026.
How has the price of NATESTO NASAL 5.5 MG/0.122 GM changed over time?
Over the history we have for it, the NADAC for NATESTO NASAL 5.5 MG/0.122 GM has risen 9.7%. It has been tracked across 186 weekly CMS publications since May 18, 2022.
What are the highest and lowest recorded NADAC prices for NATESTO NASAL 5.5 MG/0.122 GM?
Since May 18, 2022, the NADAC for NATESTO NASAL 5.5 MG/0.122 GM has ranged from a low of $37.6344 (May 18, 2022) to a high of $41.4098 (May 14, 2025), with a median of $41.2247 per GM.
Are there cheaper alternatives to NATESTO NASAL 5.5 MG/0.122 GM?
No other NADAC-published product currently shares the active ingredient and strength of NATESTO NASAL 5.5 MG/0.122 GM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NATESTO NASAL 5.5 MG/0.122 GM?
NATESTO NASAL 5.5 MG/0.122 GM (NDC 42667551101) is labeled by Acerus Pharmaceuticals Corporation, and CMS classifies it as a brand product.